Showing results (891-900 of 1,047) with videos related to
Sort By:
Pageof 105
Nature Ecology & Evolution|November 30, 2017
Direct and cascading impacts of tropical land-use change on multi-trophic biodiversityAndrew D Barnes, Kara Allen, Holger Kreft, et al.Thyroid : Official Journal of the American Thyroid Association|August 11, 2022
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)Marcia S Brose, Johannes W A Smit, Chia-Chi Lin, et al.Journal of the American College of Cardiology|February 7, 2026
Pulsed Field Ablation vs Standard Radiofrequency Ablation for Typical Atrial Flutter: ADVANTAGE AF Trial SubstudyEdward P Gerstenfeld, Boris Schmidt, Andrea Natale, et al.Thyroid : Official Journal of the American Thyroid Association|August 19, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid CancerRossella Elisei, Lori J Wirth, Jaume Capdevila, et al.Physical Medicine and Rehabilitation Clinics of North America|July 28, 2014
Functional electrical stimulation and spinal cord injuryChester H Ho, Ronald J Triolo, Anastasia L Elias, et al.Molecular Biology of the Cell|August 28, 2025
SynapseNet: Deep Learning for Automatic Synapse ReconstructionSarah Muth, Frederieke Moschref, Luca Freckmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2013
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical OncologyJyoti D Patel, Lada Krilov, Sylvia Adams, et al.The New England Journal of Medicine|November 7, 2019
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and AdolescentsShibadas Biswal, Humberto Reynales, Xavier Saez-Llorens, et al.The New England Journal of Medicine|February 12, 2015
Lenvatinib versus placebo in radioiodine-refractory thyroid cancerMartin Schlumberger, Makoto Tahara, Lori J Wirth, et al.The New England Journal of Medicine|October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid CancerJulien Hadoux, Rossella Elisei, Marcia S Brose, et al.Pageof 105